drugset / Trial / NCT01312454

Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C

NCT01312454

Phase 2 Terminated 4 enrolled Alcon Research
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study was to assess the safety and efficacy of AL-59412C injected intravitreally relative to Vehicle.

Timeline

Start
2011-06
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject AL-59412C Unknown Intravitreal
Comparator Travoprost Other / unclassified Intravitreal